Natixis United Therapeutics Corp Transaction History

Natixis

  • $17.6 Billion
  • Q3 2024

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$228.26 - $319.04 $1.53 Million - $2.14 Million
-6,716 Reduced 98.36%
112 $35,000
Q1 2024

May 13, 2024
SELL
$210.76 - $249.51 $18,546 - $21,956
-88 Reduced 1.27%
6,828 $1.57 Million
Q4 2023

Feb 13, 2024
BUY
$214.88 - $256.94 $1.33 Million - $1.6 Million
6,211 Added 880.99%
6,916 $1.52 Million
Q3 2023

Nov 14, 2023
SELL
$211.82 - $248.24 $991,105 - $1.16 Million
-4,679 Reduced 86.91%
705 $159,000
Q2 2023

Aug 11, 2023
BUY
$205.19 - $232.99 $1.07 Million - $1.22 Million
5,223 Added 3244.1%
5,384 $1.19 Million
Q1 2023

May 12, 2023
SELL
$212.99 - $276.17 $1.93 Million - $2.5 Million
-9,039 Reduced 98.25%
161 $36,000
Q4 2022

Feb 24, 2023
BUY
$205.95 - $280.43 $947,370 - $1.29 Million
4,600 Added 100.0%
9,200 $2.56 Million
Q4 2022

Feb 13, 2023
SELL
$205.95 - $280.43 $10.4 Million - $14.1 Million
-50,400 Reduced 91.64%
4,600 $1.28 Million
Q3 2022

Nov 14, 2022
BUY
$203.3 - $244.17 $8.38 Million - $10.1 Million
41,200 Added 298.55%
55,000 $11.5 Million
Q2 2022

Aug 12, 2022
SELL
$174.81 - $241.14 $19.3 Million - $26.6 Million
-110,500 Reduced 88.9%
13,800 $3.25 Million
Q1 2022

May 13, 2022
BUY
$166.16 - $213.96 $7.66 Million - $9.86 Million
46,100 Added 58.95%
124,300 $22.3 Million
Q4 2021

Feb 14, 2022
BUY
$184.32 - $216.08 $589,824 - $691,456
3,200 Added 4.27%
78,200 $16.9 Million
Q3 2021

Nov 12, 2021
BUY
$179.86 - $214.88 $1.3 Million - $1.56 Million
7,242 Added 10.69%
75,000 $13.8 Million
Q2 2019

Aug 13, 2019
BUY
$76.06 - $120.81 $2.3 Million - $3.65 Million
30,178 Added 80.3%
67,758 $5.29 Million
Q1 2019

May 15, 2019
BUY
$107.15 - $126.84 $2.02 Million - $2.39 Million
18,821 Added 100.33%
37,580 $4.41 Million
Q4 2018

Feb 14, 2019
BUY
$101.4 - $128.73 $1.9 Million - $2.41 Million
18,759 New
18,759 $2.04 Million

Others Institutions Holding UTHR

# of Institutions
672
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email